Government may lift price cap on cancer drugs making them costlier by up to 50%

India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy agents, faced shortages due to rising raw material costs. The government may allow significant price increases to boost production. This move aims to prevent treatment disruptions for thousands of patients across the nation. Revised prices are expected soon.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/TVo6ZdO
via IFTTT